Global Natural Killer Cells Therapeutics Market Status, Trends and COVID-19 Impact Report
2021
In the past few years, the Natural Killer Cells Therapeutics market experienced a huge
change under the influence of COVID-19, the global market size of Natural Killer Cells
Therapeutics reached (2021 Market size XXXX) million $ in 2021 from (2016 Market size
XXXX) in 2016 with a CAGR of 15 from 2016-2021 is. As of now, the global COVID-19
Coronavirus Cases have exceeded 200 million, and the global epidemic has been basically
under control, therefore, the World Bank has estimated the global economic growth in 2021
and 2022. The World Bank predicts that the global economic output is expected to expand 4
percent in 2021 while 3.8 percent in 2022. According to our research on Natural Killer Cells
Therapeutics market and global economic environment, we forecast that the global market
size of Natural Killer Cells Therapeutics will reach (2026 Market size XXXX) million $ in
2026 with a CAGR of % from 2021-2026.
Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk
by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to
recover and partially adapted to pandemic restrictions. The research and development of
vaccines has made breakthrough progress, and many governments have also issued various
policies to stimulate economic recovery, particularly in the United States, is likely to provide
a strong boost to economic activity but prospects for sustainable growth vary widely
between countries and sectors. Although the global economy is recovering from the great
depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged
period. The pandemic has exacerbated the risks associated with the decade-long wave of
global debt accumulation. It is also likely to steepen the long-expected slowdown in
potential growth over the next decade.
The world has entered the COVID-19 epidemic recovery period. In this complex economic
environment, we published the Global Natural Killer Cells Therapeutics Market Status,
Trends and COVID-19 Impact Report 2021, which provides a comprehensive analysis of the
global Natural Killer Cells Therapeutics market , This Report covers the manufacturer data,
including: sales volume, price, revenue, gross margin, business distribution etc., these data
help the consumer know about the competitors better. This report also covers all the
regions and countries of the world, which shows the regional development status, including
market size, volume and value, as well as price data. Besides, the report also covers segment
data, including: type wise, industry wise, channel wise etc. all the data period is from 2015-
2021E, this report also provide forecast data from 2021-2026.
Market Overview
Manufacturer Detail
Affimed
Celgene
Fate Therapeutics
Fortress Biotech
Glycostem Therapeutics
Innate Pharma
Nantkwest
Nkarta Therapeutics
NKT Therapeutics
Ziopharm Oncology
Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)
Product Type Segmentation
NK Cell Therapies
NK Cell Directed Antibodies
Application Segmentation
Cancer
Gastrointestinal Diseases
Immunoproliferative Disorders
Table of Contents
Section 1 Natural Killer Cells Therapeutics Market Overview
1.1 Natural Killer Cells Therapeutics Market Scope
1.2 COVID-19 Impact on Natural Killer Cells Therapeutics Market
1.3 Global Natural Killer Cells Therapeutics Market Status and Forecast Overview
1.3.1 Global Natural Killer Cells Therapeutics Market Status 2016-2021
1.3.2 Global Natural Killer Cells Therapeutics Market Forecast 2021-2026
Section 2 Global Natural Killer Cells Therapeutics Market Manufacturer Share
2.1 Global Manufacturer Natural Killer Cells Therapeutics Sales Volume
2.2 Global Manufacturer Natural Killer Cells Therapeutics Business Revenue
Section 3 Manufacturer Natural Killer Cells Therapeutics Business Introduction
3.1 Affimed Natural Killer Cells Therapeutics Business Introduction
3.1.1 Affimed Natural Killer Cells Therapeutics Sales Volume, Price, Revenue and Gross
margin 2016-2021
3.1.2 Affimed Natural Killer Cells Therapeutics Business Distribution by Region
3.1.3 Affimed Interview Record
3.1.4 Affimed Natural Killer Cells Therapeutics Business Profile
3.1.5 Affimed Natural Killer Cells Therapeutics Product Specification
3.2 Celgene Natural Killer Cells Therapeutics Business Introduction
3.2.1 Celgene Natural Killer Cells Therapeutics Sales Volume, Price, Revenue and Gross
margin 2016-2021
3.2.2 Celgene Natural Killer Cells Therapeutics Business Distribution by Region
3.2.3 Interview Record
3.2.4 Celgene Natural Killer Cells Therapeutics Business Overview
3.2.5 Celgene Natural Killer Cells Therapeutics Product Specification
3.3 Manufacturer three Natural Killer Cells Therapeutics Business Introduction
3.3.1 Manufacturer three Natural Killer Cells Therapeutics Sales Volume, Price, Revenue and
Gross margin 2016-2021
3.3.2 Manufacturer three Natural Killer Cells Therapeutics Business Distribution by Region
3.3.3 Interview Record
3.3.4 Manufacturer three Natural Killer Cells Therapeutics Business Overview
3.3.5 Manufacturer three Natural Killer Cells Therapeutics Product Specification
Section 4 Global Natural Killer Cells Therapeutics Market Segmentation (By Region)
4.1 North America Country
4.1.1 United States Natural Killer Cells Therapeutics Market Size and Price Analysis 2016-
2021
4.1.2 Canada Natural Killer Cells Therapeutics Market Size and Price Analysis 2016-2021
4.1.3 Mexico Natural Killer Cells Therapeutics Market Size and Price Analysis 2016-2021
4.2 South America Country
4.2.1 Brazil Natural Killer Cells Therapeutics Market Size and Price Analysis 2016-2021
4.2.2 Argentina Natural Killer Cells Therapeutics Market Size and Price Analysis 2016-2021
4.3 Asia Pacific
4.3.1 China Natural Killer Cells Therapeutics Market Size and Price Analysis 2016-2021
4.3.2 Japan Natural Killer Cells Therapeutics Market Size and Price Analysis 2016-2021
4.3.3 India Natural Killer Cells Therapeutics Market Size and Price Analysis 2016-2021
4.3.4 Korea Natural Killer Cells Therapeutics Market Size and Price Analysis 2016-2021
4.3.5 Southeast Asia Natural Killer Cells Therapeutics Market Size and Price Analysis 2016-
2021
4.4 Europe Country
4.4.1 Germany Natural Killer Cells Therapeutics Market Size and Price Analysis 2016-2021
4.4.2 UK Natural Killer Cells Therapeutics Market Size and Price Analysis 2016-2021
4.4.3 France Natural Killer Cells Therapeutics Market Size and Price Analysis 2016-2021
4.4.4 Spain Natural Killer Cells Therapeutics Market Size and Price Analysis 2016-2021
4.4.5 Italy Natural Killer Cells Therapeutics Market Size and Price Analysis 2016-2021
4.5 Middle East and Africa
4.5.1 Africa Natural Killer Cells Therapeutics Market Size and Price Analysis 2016-2021
4.5.2 Middle East Natural Killer Cells Therapeutics Market Size and Price Analysis 2016-
2021
4.6 Global Natural Killer Cells Therapeutics Market Segmentation (By Region) Analysis
2016-2021
4.7 Global Natural Killer Cells Therapeutics Market Segmentation (By Region) Analysis
Section 5 Global Natural Killer Cells Therapeutics Market Segmentation (by Product Type)
5.1 Product Introduction by Type
5.1.1 NK Cell Therapies Product Introduction
5.1.2 NK Cell Directed Antibodies Product Introduction
5.2 Global Natural Killer Cells Therapeutics Sales Volume by NK Cell Directed
Antibodies016-2021
5.3 Global Natural Killer Cells Therapeutics Market Size by NK Cell Directed Antibodies016-
2021
5.4 Different Natural Killer Cells Therapeutics Product Type Price 2016-2021
5.5 Global Natural Killer Cells Therapeutics Market Segmentation (By Type) Analysis
Section 6 Global Natural Killer Cells Therapeutics Market Segmentation (by Application)
6.1 Global Natural Killer Cells Therapeutics Sales Volume by Application 2016-2021
6.2 Global Natural Killer Cells Therapeutics Market Size by Application 2016-2021
6.2 Natural Killer Cells Therapeutics Price in Different Application Field 2016-2021
6.3 Global Natural Killer Cells Therapeutics Market Segmentation (By Application) Analysis
Section 7 Global Natural Killer Cells Therapeutics Market Segmentation (by Channel)
7.1 Global Natural Killer Cells Therapeutics Market Segmentation (By Channel) Sales
Volume and Share 2016-2021
7.2 Global Natural Killer Cells Therapeutics Market Segmentation (By Channel) Analysis
Section 8 Natural Killer Cells Therapeutics Market Forecast 2021-2026
8.1 Natural Killer Cells Therapeutics Segmentation Market Forecast 2021-2026 (By Region)
8.2 Natural Killer Cells Therapeutics Segmentation Market Forecast 2021-2026 (By Type)
8.3 Natural Killer Cells Therapeutics Segmentation Market Forecast 2021-2026 (By
Application)
8.4 Natural Killer Cells Therapeutics Segmentation Market Forecast 2021-2026 (By
Channel)
8.5 Global Natural Killer Cells Therapeutics Price Forecast
Section 9 Natural Killer Cells Therapeutics Application and Client Analysis
9.1 Cancer Customers
9.2 Gastrointestinal Diseases Customers
9.3 Immunoproliferative Disorders Customers
Section 10 Natural Killer Cells Therapeutics Manufacturing Cost of Analysis
11.0 Raw Material Cost Analysis
11.0 Labor Cost Analysis
11.0 Cost Overview
Section 11 Conclusion
Section 12 Methodology and Data Source
Chart and Figure
Figure Natural Killer Cells Therapeutics Product Picture
Chart Global Natural Killer Cells Therapeutics Market Size (with or without the impact of
COVID-19)
Chart Global Natural Killer Cells Therapeutics Sales Volume (Units) and Growth Rate 2016-
2021
Chart Global Natural Killer Cells Therapeutics Market Size (Million $) and Growth Rate
2016-2021
Chart Global Natural Killer Cells Therapeutics Sales Volume (Units) and Growth Rate 2021-
2026
Chart Global Natural Killer Cells Therapeutics Market Size (Million $) and Growth Rate
2021-2026